JFS Wealth Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.33K | Sell |
54
-35
| -39% | -$1.51K | ﹤0.01% | 1353 |
|
|
2025
Q1 | $3.08K | Buy |
89
+48
| +117% | +$1.66K | ﹤0.01% | 1311 |
|
|
2024
Q4 | $1.13K | Sell |
41
-38
| -48% | -$1.04K | ﹤0.01% | 1651 |
|
|
2024
Q3 | $2.01K | Hold |
79
| – | – | ﹤0.01% | 1488 |
|
|
2024
Q2 | $2K | Buy |
79
+19
| +32% | +$481 | ﹤0.01% | 1429 |
|
|
2024
Q1 | $1.86K | Hold |
60
| – | – | ﹤0.01% | 1474 |
|
|
2023
Q4 | $2.42K | Buy |
60
+21
| +54% | +$848 | ﹤0.01% | 1346 |
|
|
2023
Q3 | $1.03K | Buy |
39
+3
| +8% | +$79 | ﹤0.01% | 1588 |
|
|
2023
Q2 | $620 | Buy |
36
+8
| +29% | +$138 | ﹤0.01% | 1716 |
|
|
2023
Q1 | $465 | Buy |
28
+5
| +22% | +$83 | ﹤0.01% | 1729 |
|
|
2022
Q4 | $175 | Sell |
23
-7
| -23% | -$53 | ﹤0.01% | 1840 |
|
|
2022
Q3 | $0 | Buy |
30
+16
| +114% | – | ﹤0.01% | 1739 |
|
|
2022
Q2 | $0 | Sell |
14
-1
| -7% | – | ﹤0.01% | 1737 |
|
|
2022
Q1 | $0 | Sell |
15
-10
| -40% | – | ﹤0.01% | 1820 |
|
|
2021
Q4 | $0 | Buy |
+25
| New | – | ﹤0.01% | 1712 |
|